ATE510905T1 - Verfahren zur isolierung von bipotenten lebervorläuferzellen - Google Patents

Verfahren zur isolierung von bipotenten lebervorläuferzellen

Info

Publication number
ATE510905T1
ATE510905T1 AT00968708T AT00968708T ATE510905T1 AT E510905 T1 ATE510905 T1 AT E510905T1 AT 00968708 T AT00968708 T AT 00968708T AT 00968708 T AT00968708 T AT 00968708T AT E510905 T1 ATE510905 T1 AT E510905T1
Authority
AT
Austria
Prior art keywords
progenitors
cells
hepatic
antigen
cell
Prior art date
Application number
AT00968708T
Other languages
English (en)
Inventor
Hiroshi Kubota
Lola Reid
Original Assignee
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina filed Critical Univ North Carolina
Application granted granted Critical
Publication of ATE510905T1 publication Critical patent/ATE510905T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/067Hepatocytes
    • C12N5/0672Stem cells; Progenitor cells; Precursor cells; Oval cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/11Epidermal growth factor [EGF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/13Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00968708T 2000-10-03 2000-10-03 Verfahren zur isolierung von bipotenten lebervorläuferzellen ATE510905T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/027429 WO2002028997A2 (en) 2000-10-03 2000-10-03 Methods of isolating bipotent hepatic progenitor cells

Publications (1)

Publication Number Publication Date
ATE510905T1 true ATE510905T1 (de) 2011-06-15

Family

ID=21741847

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00968708T ATE510905T1 (de) 2000-10-03 2000-10-03 Verfahren zur isolierung von bipotenten lebervorläuferzellen

Country Status (11)

Country Link
EP (1) EP1325112B1 (de)
JP (1) JP2004510432A (de)
CN (1) CN1258589C (de)
AT (1) ATE510905T1 (de)
AU (2) AU7858200A (de)
CA (1) CA2424781C (de)
DK (1) DK1325112T3 (de)
ES (1) ES2367005T3 (de)
HK (1) HK1054569B (de)
IL (2) IL155249A0 (de)
WO (1) WO2002028997A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020187133A1 (en) 1999-10-01 2002-12-12 Hiroshi Kubota Methods of isolating bipotent hepatic progenitor cells
JP2004510434A (ja) * 2000-10-03 2004-04-08 ユニバーシティ オブ ノース カロライナ 肝前駆細胞のクローン増殖方法
DE60232322D1 (de) 2001-03-27 2009-06-25 Vertex Pharma Verfahren
EP1956078A3 (de) 2001-06-22 2008-10-29 StemCells, Inc. Zellen zur Einpflanzung in die Leber, Assays dafür und Verwendungen davon
US20060040386A1 (en) * 2004-01-14 2006-02-23 Suchitra Holgersson Human hepatic progenitor cells and methods of use thereof
US8951792B2 (en) 2007-07-20 2015-02-10 Cellartis Ab Methods for making definitive endoderm hepatocyte (DE-hep) progenitor cells
ES2659764T3 (es) * 2011-08-23 2018-03-19 Roche Glycart Ag Moléculas biespecíficas de unión a antígeno activadoras de linfocitos T
KR20190003833A (ko) 2014-08-28 2019-01-09 프로메테라 바이오사이언시즈 에스.에이./엔.브이. 성체 간 전구 세포의 제조 방법
SG10202009095VA (en) 2014-11-26 2020-10-29 Accelerated Biosciences Corp Induced hepatocytes and uses thereof
JP6704617B2 (ja) * 2016-01-29 2020-06-03 北海道公立大学法人 札幌医科大学 小型肝細胞の継代培養方法
CN109385394A (zh) * 2018-11-02 2019-02-26 大连理工大学 一种提取、分离和培养同体异种肝原代细胞的方法
WO2020120664A1 (en) * 2018-12-14 2020-06-18 Promethera Biosciences S.A./N.V. Cell composition comprising liver progenitor cells expressing hla-e

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6129911A (en) * 1998-07-10 2000-10-10 Rhode Island Hospital, A Lifespan Partner Liver stem cell
WO2000043498A2 (en) * 1999-01-19 2000-07-27 University Of North Carolina At Chapel Hill Human liver progenitors

Also Published As

Publication number Publication date
CN1258589C (zh) 2006-06-07
EP1325112A2 (de) 2003-07-09
EP1325112B1 (de) 2011-05-25
IL155249A0 (en) 2003-11-23
WO2002028997A3 (en) 2002-09-12
AU2000278582B2 (en) 2007-08-30
AU7858200A (en) 2002-04-15
DK1325112T3 (da) 2011-09-12
ES2367005T3 (es) 2011-10-27
CA2424781A1 (en) 2002-04-11
HK1054569A1 (en) 2003-12-05
WO2002028997A2 (en) 2002-04-11
CA2424781C (en) 2018-11-06
HK1054569B (en) 2012-03-02
IL155249A (en) 2011-12-29
JP2004510432A (ja) 2004-04-08
CN1461340A (zh) 2003-12-10

Similar Documents

Publication Publication Date Title
Joseph et al. Urethral luminal epithelia are castration‐insensitive cells of the proximal prostate
Zhao et al. Differentiation of human umbilical cord mesenchymal stromal cells into low immunogenic hepatocyte-like cells
ATE510905T1 (de) Verfahren zur isolierung von bipotenten lebervorläuferzellen
Driscoll et al. Establishment of immortalized alveolar type II epithelial cell lines from adult rats
Zeddou et al. The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood
Blais et al. Common characteristics for Na+-dependent sugar transport in Caco-2 cells and human fetal colon
Lawson et al. Stem cells in prostate cancer initiation and progression
Shafritz et al. Liver stem cells and model systems for liver repopulation
Wei et al. FOXF1 mediates mesenchymal stem cell fusion-induced reprogramming of lung cancer cells
Bonilla et al. Functional neural stem cells derived from adult bone marrow
Langergraber et al. How old are chimpanzee communities? Time to the most recent common ancestor of the Y-chromosome in highly patrilocal societies
Sternberg-Simon et al. Natural killer cell inhibitory receptor expression in humans and mice: a closer look
DK1147179T3 (da) Humane lever-progenitorer
ATE449837T1 (de) Abstammungs-spezifische zellen und vorläuferzellen
WO2003104411A3 (en) BIOARTIFICIAL LIVER SYSTEM
DE69739480D1 (de) Menschliche hämatopoietische stamm und vorläuferzellantigen und methoden zu dessen verwendung
Bao et al. Establishment and characterization of immortalized gingival epithelial and fibroblastic cell lines for the development of organotypic cultures
JP2012507304A5 (de)
O'Connor et al. Differentiation rather than aging of muscle stem cells abolishes their telomerase activity
CN101553564A (zh) 肝星状细胞前体及其分离方法
Cunningham et al. Regulation and function of adhesion molecule expression by human alveolar epithelial cells
BRPI0710339A2 (pt) método de modulação de uma reação imunólogica, método de redução e extrato
Su et al. Establishment and evaluation of a stable cattle type II alveolar epithelial cell line
Garcia et al. Intercomparison in cytogenetic dosimetry among five laboratories from Latin America
DE60115225D1 (de) Verfahren zur bestimmung einer genfunktion

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1325112

Country of ref document: EP